Gene · 8754
Papers1,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole genome sequencing of HER2-positive metastatic extramammary Paget's disease: a case report. | Orphanet J Rare Dis | 2024 | 38831459 | PubTator, text mining | PubMed |
| Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein. | J Biol Chem | 2024 | 38777146 | PubTator, text mining | PubMed |
| ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection. | Nat Commun | 2024 | 38755212 | PubTator, text mining | PubMed |
| ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression. | Am J Cancer Res | 2024 | 38726266 | PubTator, text mining | PubMed |
| Exploring Potential Biomarkers in Oesophageal Cancer: A Comprehensive Analysis. | Int J Mol Sci | 2024 | 38673838 | PubTator, text mining | PubMed |
| Identification of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma. | Technol Cancer Res Treat | 2024 | 38613350 | PubTator, text mining | PubMed |
| Exploring the oncogenic and tumor-suppressive roles of Circ-ADAM9 in cancer. | Pathol Res Pract | 2024 | 38537524 | PubTator, text mining | PubMed |
| A Disintegrin and metalloproteinase carves T cell abnormalities and pathogenesis in systemic lupus erythematosus. | Clin Immunol | 2024 | 38458301 | PubTator, text mining | PubMed |
| [Retracted] MicroRNA‑140 represses glioma growth and metastasis by directly targeting ADAM9. | Oncol Rep | 2024 | 38456498 | PubTator, text mining | PubMed |
| Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma. | PLoS One | 2024 | 38306361 | PubTator, text mining | PubMed |
| [Retracted] MicroRNA‑30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9. | Oncol Lett | 2024 | 38298431 | PubTator, text mining | PubMed |
| Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy. | Nat Cancer | 2024 | 38267627 | PubTator, text mining | PubMed |
| Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study. | Int J Mol Sci | 2024 | 38256049 | PubTator, text mining | PubMed |
| MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC). | Cancers (Basel) | 2024 | 38254761 | PubTator, text mining | PubMed |
| DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts. | Nat Commun | 2024 | 38242884 | PubTator, text mining | PubMed |
| Retracted: mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9. | Biomed Res Int | 2024 | 38230011 | PubTator, text mining | PubMed |
| Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis. | Cancer Cell Int | 2024 | 38200479 | PubTator, text mining | PubMed |
| Transcriptomic signatures of individual cell types in cerebral cavernous malformation. | Cell Commun Signal | 2024 | 38195510 | PubTator, text mining | PubMed |
| Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targets. | Noncoding RNA Res | 2024 | 38192436 | PubTator, text mining | PubMed |
| Soluble receptors in cancer: mechanisms, clinical significance, and therapeutic strategies. | Exp Mol Med | 2024 | 38182653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8754/papers?page=5